SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
830.00    14.00 (1.72%)
Bid:
824.00
Ask:
828.00
Spread: 4.00 (0.485%)
Market Cap: £382.60m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Board Changes

25 Sep 2025 07:00

RNS Number : 6929A
Porvair PLC
25 September 2025
 

 

For immediate release 25 September 2025

 

 

Porvair plc

("Porvair" or the "Group" or the "Company")

 

Board Changes

Lisa Anson

Lisa Anson has been appointed as Non-Executive Director of the Company with effect from 1 October 2025.

Lisa is currently Chief Executive Officer of Redx Pharma limited, a UK based, privately held clinical-stage biotech business; a position she held when Redx was publicly listed on AIM. In addition, she is a Supervisory Board Member for Apoplex Medical Technologies GmBH, a private German company and is an elected Board Member of the UK BioIndustry Association (BIA). She was previously a Board Member and then Chair at the Association of the British Pharmaceutical Industry (ABPI).

Lisa's career spans almost 30 years in the pharmaceutical and Biotech industry including more than twenty years at AstraZeneca Plc. She has extensive global leadership and commercial experience, including several USA based roles and most recently was Country President for the UK and Ireland.

On appointment, Lisa will join the Audit Committee, Remuneration Committee and Nomination Committee of Porvair.

Porvair confirms that there are no further matters in relation to Lisa Anson's appointment to be disclosed pursuant to the requirements of paragraph 6.4.8 of the Listing Rules of the UK Listing Authority.

Sally Martin

Having completed 9 years as a Non-Executive Director at Porvair, Sally Martin will retire from the Board on 4 November 2025.

Sheena Mackay

Following Sally's retirement, Sheena Mackay will be appointed Senior Independent Director of the Board and the Non-Executive Director responsible for employee engagement, in addition to her role as Chair of the Remuneration Committee.

For further information, please contact:

Porvair plc

+44 (0)1553 765 500

Hooman Caman Javvi, Chief Executive Officer

Andrew Douglass, Group Company Secretary

 

Burson Buchanan

+44 (0)207 466 5000

Charles Ryland / Stephanie Whitmore

 

 

Notes to editors

 

Porvair plc

Porvair is a group of specialist filtration, laboratory and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEZLFLEKLZBBF
Date   Source Headline
17th Apr 20077:02 amRNSRe Contract
19th Mar 20076:23 pmRNSHolding in Company
19th Mar 20076:18 pmRNSHolding in Company
13th Feb 20073:54 pmRNSHolding(s) in Company
8th Feb 20077:00 amRNSContract Win
5th Feb 20075:45 pmRNSHolding(s) in Company
30th Jan 20077:01 amRNSBoard Appointment
30th Jan 20077:01 amRNSPreliminary Results
22nd Jan 20077:01 amRNSAcquisition
19th Dec 20067:01 amRNSTotal Voting Rights
15th Dec 20065:14 pmRNSTransaction in Own Shares
11th Dec 20067:01 amRNSTrading Update
15th Nov 200611:30 amRNSHolding(s) in Company
13th Nov 20065:47 pmRNSHolding(s) in Company
3rd Oct 20069:21 amRNSChange of Adviser
13th Jul 20065:07 pmRNSHolding(s) in Company
4th Jul 20067:01 amRNSInterim Results
20th Jun 20069:48 amRNSNotice of Results
19th May 20067:00 amRNSTransition to IFRS
11th May 20064:17 pmRNSHolding(s) in Company
5th May 200611:24 amRNSSAR 3 - Porvair Plc
21st Apr 20064:31 pmRNSRetirement of Chairman
22nd Mar 20062:37 pmRNSAdditional Listing
8th Mar 20065:16 pmRNSAnnual Report & Accounts, etc
21st Feb 20063:30 pmRNSHolding(s) in Company
10th Feb 20063:04 pmRNSAdditional Listing
24th Jan 20064:23 pmRNSHolding(s) in Company
24th Jan 20067:00 amRNSFinal Results
21st Dec 200511:32 amRNSDirector/PDMR Shareholding
7th Dec 200511:13 amRNSNotice of Results
2nd Dec 20051:25 pmRNSHolding(s) in Company
22nd Nov 20056:17 pmRNSHolding(s) in Company
21st Nov 20055:17 pmRNSDirector/PDMR Shareholding
18th Nov 20053:34 pmRNSResult of EGM
27th Oct 20054:12 pmRNSProposed Acquisition
31st Aug 20053:13 pmRNSHolding(s) in Company
10th Aug 20056:18 pmRNSHolding(s) in Company
3rd Aug 200510:31 amRNSHolding(s) in Company
1st Aug 200512:01 pmRNSSAR 3 - Porvair Plc
26th Jul 200512:56 pmRNSHolding(s) in Company
26th Jul 200511:25 amRNSNotice of Filing
25th Jul 200511:28 amRNSSAR 3 - Porvair
28th Jun 20057:00 amRNSInterim Results
13th Jun 20057:00 amRNSSupply Agreement Win
9th Jun 20054:33 pmRNSNotice of Results
6th May 20056:08 pmRNSHolding(s) in Company-Replace
6th May 20055:20 pmRNSHolding(s) in Company
17th Mar 20052:48 pmRNSHolding(s) in Company
10th Mar 20057:00 amRNSRe Agreement
14th Feb 200510:21 amRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.